Results 331 to 340 of about 3,292,689 (405)
Some of the next articles are maybe not open access.
Journal of Clinical Neuroscience, 2015
We review the etiology, investigations, management and outcomes of pituitary tumor apoplexy. Pituitary tumor apoplexy is a clinical syndrome which typically includes the acute onset of headache and/or visual disturbance, cranial nerve palsy and partial or complete endocrine dysfunction.
Philip C, Johnston +3 more
openaire +3 more sources
We review the etiology, investigations, management and outcomes of pituitary tumor apoplexy. Pituitary tumor apoplexy is a clinical syndrome which typically includes the acute onset of headache and/or visual disturbance, cranial nerve palsy and partial or complete endocrine dysfunction.
Philip C, Johnston +3 more
openaire +3 more sources
Familial Pituitary Tumor Syndromes
Endocrine Practice, 2011To summarize current knowledge on the clinical and genetic characteristics of familial pituitary tumor syndromes.This review is based on a comprehensive search through the English-language literature with use of the following terms: "familial," "pituitary," "adenomas," and "tumors."Familial pituitary tumors are rare and constitute approximately 5% of ...
Vasilev, Vladimir +4 more
openaire +4 more sources
Current Opinion in Neurology, 2012
The aim of this article is to review current research in the treatment of pituitary tumors and summarize emerging medical, surgical and radiation-based therapies.Existing medical agents such as dopamine agonists and somatostatin ligand receptors are being used in novel combinations to achieve biochemical remission for pituitary tumors and reduce tumor ...
Gautam U, Mehta, John A, Jane
openaire +2 more sources
The aim of this article is to review current research in the treatment of pituitary tumors and summarize emerging medical, surgical and radiation-based therapies.Existing medical agents such as dopamine agonists and somatostatin ligand receptors are being used in novel combinations to achieve biochemical remission for pituitary tumors and reduce tumor ...
Gautam U, Mehta, John A, Jane
openaire +2 more sources
Current Treatment Options in Neurology, 2009
Pituitary adenomas are the most common intrasellar tumors. With the exception of prolactinomas, first-line treatment is almost always surgical. Prolactinomas are usually treated with dopamine agonists such as cabergoline or bromocriptine. Somatostatin analogues, such as octreotide and lanreotide, can be adjunctive to surgical therapy in acromegaly ...
Nestoras, Mathioudakis +1 more
openaire +2 more sources
Pituitary adenomas are the most common intrasellar tumors. With the exception of prolactinomas, first-line treatment is almost always surgical. Prolactinomas are usually treated with dopamine agonists such as cabergoline or bromocriptine. Somatostatin analogues, such as octreotide and lanreotide, can be adjunctive to surgical therapy in acromegaly ...
Nestoras, Mathioudakis +1 more
openaire +2 more sources
Clinics in Laboratory Medicine, 1984
The most frequent pituitary neoplasm is the adenoma, which can produce signs and symptoms owing to mass effects or secretion of pituitary hormones. The authors discuss these mass effects of pituitary tumors on the endocrine system and excess hormone secretion by pituitary adenomas.
J H, Howanitz, P J, Howanitz
openaire +2 more sources
The most frequent pituitary neoplasm is the adenoma, which can produce signs and symptoms owing to mass effects or secretion of pituitary hormones. The authors discuss these mass effects of pituitary tumors on the endocrine system and excess hormone secretion by pituitary adenomas.
J H, Howanitz, P J, Howanitz
openaire +2 more sources
Neurosurgery, 1991
Abstract This retrospective review of pediatric patients with pituitary tumors causing onset of symptoms by 17 years of age was done to define their pathological distribution, clinical presentation, treatment, and prognosis. Eighteen patients were evaluated and treated from 1979 to 1989.
S F, Haddad +2 more
openaire +2 more sources
Abstract This retrospective review of pediatric patients with pituitary tumors causing onset of symptoms by 17 years of age was done to define their pathological distribution, clinical presentation, treatment, and prognosis. Eighteen patients were evaluated and treated from 1979 to 1989.
S F, Haddad +2 more
openaire +2 more sources
Pituitary enlargement mimicking pituitary tumor
Journal of Neurosurgery, 1985✓ Primary hypothyroidism can result in reactive enlargement of the pituitary gland which is indistinguishable from primary pituitary lesions on computerized tomography (CT) scans. The presenting symptoms may be due to pituitary gland enlargement, as in two of the three cases reported here.
L T, Bilaniuk +6 more
openaire +2 more sources
Pituitary hyperplasia mimicking pituitary tumor
Surgical Neurology, 1994Reactive enlargement of the pituitary gland in primary end organ failure may be indistinguishable from primary pituitary lesions in clinical presentation and on magnetic resonance imaging. The diagnosis of pituitary hyperplasia secondary to end organ failure must be based on endocrinologic investigations.
M C, Dadachanji +2 more
openaire +2 more sources
Neurologic Clinics, 1985
Great strides have been made in the understanding of anatomy, physiology, pathology, diagnosis, and treatment of pituitary adenomas. The single greatest credit should probably be given to the rapid advancement in surgical techniques that ushered in a new era of multispecialty interest in the pituitary and its disorders.
openaire +2 more sources
Great strides have been made in the understanding of anatomy, physiology, pathology, diagnosis, and treatment of pituitary adenomas. The single greatest credit should probably be given to the rapid advancement in surgical techniques that ushered in a new era of multispecialty interest in the pituitary and its disorders.
openaire +2 more sources
Aggressive Pituitary Tumors or Localized Pituitary Carcinomas: Defining Pituitary Tumors
Expert Review of Endocrinology & Metabolism, 2016Pituitary tumors are common and exhibit a wide spectrum of hormonal, proliferative and invasive behaviors. Traditional classifications consider them malignant only when they exhibit metastasis. Patients who suffer morbidity and mortality from aggressive tumors classified as "adenomas" are denied support provided to patients with "cancers" and in many ...
Sylvia L, Asa, Shereen, Ezzat
openaire +2 more sources